SCHEMBL8914912

SCHEMBL8914912

N#CNC(=Nc1ccncc1)NCCOc1ccc(Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
IKBKB O14920 1/20 0.48
NPC1 O15118 2/20 0.42
RAB9A P51151 1/20 0.42
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.40
HRH4 Q9H3N8 1/20 0.38
MAPT P10636 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 2/20 0.37
NPY1R P25929 1/20 0.37
NPY2R P49146 1/20 0.37
MMP3 P08254 1/20 0.37
ATM Q13315 1/20 0.37
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8195513 0.93 NAMPT (0.53) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL8195515 0.93 NAMPT (0.53) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL504983 0.92 NAMPT (0.61) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL504863 0.92 NAMPT (0.61) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL504126 0.92 NAMPT (0.61) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL504982 0.92 NAMPT (0.61) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
Chs-828 SCHEMBL504892 0.92 NAMPT (0.61) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
Chs-828 SCHEMBL504151 0.92 NAMPT (0.61) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL505054 0.92 NAMPT (0.61) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL504997 0.92 NAMPT (0.61) NAMPTCYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5696140-A FOR TREATMENT OF ASTHMA, ALLERGIES, NERVOUS SYSTEM DISORDERS OR CANCER LEO PHARMACEUTICAL PRODUCTS LTD. (DK) 1997-12-09 US disclosed
US-5563160-A NERVOUS SYSTEM DISORDERS, ANTIHISTAMINE, ANTIALLERGENS Leo Pharmaceutical Products Ltd. A/S (L.o slashed.vens Kemiske Fabrik Produktionsaktieselskab) (DK) 1996-10-08 US disclosed
EP-0660823-B1 N-CYANO-N'-PYRIDYLGUANIDINES AS SEROTONIN ANTAGONISTS LEO PHARM PROD LTD (DK) 1996-08-14 EP disclosed